Alpha-2 agonist (topical)
Brimonidine
Clear to pale gel
Typical Strength
0.33% (common)
Formulations
1 compounds
Formula
C₁₁H₁₀BrN₅
Mol. Weight
292.14 g/mol
How It Works
Mechanism of action
Selective alpha-2 adrenergic agonist causing vasoconstriction of dilated facial vessels. Reduces rosacea redness within hours. Compounding allows pairing with anti-inflammatories and adjusting strength to limit rebound flushing.
What compounding can change
When Brimonidine is compounded for one patient, your prescriber can choose the concentration, combine it with other ingredients, and pick the base. Commercial products come in fixed strengths and bases.
Safety Considerations
Commonly paired with
These ingredients frequently appear alongside Brimonidine in our formulations.
Please note: Compounded medications require a prescription from a licensed prescriber for an individual patient. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness or quality. A compounded medication is not the same as, or a generic version of, any FDA-approved drug. This page is general information, not medical advice. Your prescriber decides whether a treatment is right for you and sets the final ingredients, strength and dosage form.